Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy.

Hornigold N, Johnson TS, Huang L, Haylor JL, Griffin M, Mooney A.

Lab Invest. 2013 May;93(5):553-65. doi: 10.1038/labinvest.2013.42. Epub 2013 Mar 18.

2.

Extracellular matrix-induced Hic-5 expression in glomerular mesangial cells leads to a prosclerotic phenotype independent of TGF-β.

Hornigold N, Mooney A.

FASEB J. 2015 Dec;29(12):4956-67. doi: 10.1096/fj.14-269894. Epub 2015 Sep 24.

PMID:
26405299
3.

Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.

Sanai T, Sobka T, Johnson T, el-Essawy M, Muchaneta-Kubara EC, Ben Gharbia O, el Oldroyd S, Nahas AM.

Diabetologia. 2000 Jan;43(1):91-100.

PMID:
10663221
4.

Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.

Matsubara T, Abe H, Arai H, Nagai K, Mima A, Kanamori H, Sumi E, Takahashi T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.

Lab Invest. 2006 Apr;86(4):357-68.

5.

Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosis.

Hornigold N, Craven RA, Keen JN, Johnson T, Banks RE, Mooney AF.

Kidney Int. 2010 Feb;77(4):329-38. doi: 10.1038/ki.2009.417. Epub 2009 Dec 9.

6.

Glomerular expression of hydrogen peroxide-inducible clone-5 in human and rat progressive mesangial proliferative glomerulonephritis.

Suga K, Kondo S, Matsuura S, Kinoshita Y, Urushihara M, Kagami S.

Nephron Exp Nephrol. 2012;120(2):e59-68. doi: 10.1159/000335780. Epub 2012 Jan 27.

PMID:
22286178
7.

Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.

Liu M, Zhang Y, Chi Y, Zhai S, Wang B, Shi Y, Li Y.

J Nephrol. 2012 May-Jun;25(3):418-25. doi: 10.5301/jn.5000019.

PMID:
21928229
8.

Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells.

Loeffler I, Hopfer U, Koczan D, Wolf G.

J Am Soc Nephrol. 2011 Apr;22(4):649-63. doi: 10.1681/ASN.2010010098. Epub 2011 Mar 3.

9.

Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.

Jamba A, Kondo S, Urushihara M, Nagai T, Kim-Kaneyama JR, Miyazaki A, Kagami S.

PLoS One. 2015 Apr 2;10(4):e0122773. doi: 10.1371/journal.pone.0122773. eCollection 2015.

10.

Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.

Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG.

J Am Soc Nephrol. 2000 Jan;11(1):25-38.

11.

The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats.

Liu D, Razzaque MS, Cheng M, Taguchi T.

Histochem J. 2001 Nov-Dec;33(11-12):621-8.

PMID:
12197670
12.

Mechanisms through which bradykinin promotes glomerular injury in diabetes.

Tan Y, Wang B, Keum JS, Jaffa AA.

Am J Physiol Renal Physiol. 2005 Mar;288(3):F483-92.

PMID:
15692059
13.

Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.

Ceol M, Nerlich A, Baggio B, Anglani F, Sauer U, Schleicher E, Gambaro G.

Lab Invest. 1996 Feb;74(2):484-95.

PMID:
8780166
14.

Glomerular barrier dysfunction in glomerulosclerosis- resistant Milan rats with experimental diabetes: the role of renal haemodynamics.

Pugliese G, Ricci C, Iacobini C, Menini S, Fioretto P, Ferrandi M, Giardino LA, Armelloni S, Mattinzoli D, Rastaldi MP, Pugliese F.

J Pathol. 2007 Oct;213(2):210-8. Erratum in: J Pathol. 2007 Oct;213(2):218.

PMID:
17768702
15.
16.

Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.

Seo JY, Park J, Yu MR, Kim YS, Ha H, Lee HB.

Am J Nephrol. 2009;30(6):481-90. doi: 10.1159/000242477. Epub 2009 Sep 25.

PMID:
19786738
17.

Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.

Mima A, Matsubara T, Arai H, Abe H, Nagai K, Kanamori H, Sumi E, Takahashi T, Iehara N, Fukatsu A, Kita T, Doi T.

Lab Invest. 2006 Sep;86(9):927-39. Epub 2006 Jun 12. Erratum in: Lab Invest. 2012 May;92(5):797.

18.

Hepatocyte growth factor-induced amelioration in chronic renal failure is associated with reduced expression of α-smooth muscle actin.

Wang HY, Yang LZ, Cui MJ, Gu CM, Zhao Y, Chen Y, Zhao D, Li TS, Chi B.

Ren Fail. 2012;34(7):862-70. doi: 10.3109/0886022X.2012.687344. Epub 2012 Jun 8.

PMID:
22680062
19.

Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.

Ju KD, Shin EK, Cho EJ, Yoon HB, Kim HS, Kim H, Yang J, Hwang YH, Ahn C, Oh KH.

Am J Physiol Renal Physiol. 2012 Mar 1;302(5):F606-13. doi: 10.1152/ajprenal.00415.2011. Epub 2011 Nov 30.

PMID:
22129969
20.

Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.

Li Z, Zhang H, Dong X, Burczynski FJ, Choy P, Yang F, Liu H, Li P, Gong Y.

Biochem Cell Biol. 2010 Aug;88(4):635-48. doi: 10.1139/O09-185.

PMID:
20651835

Supplemental Content

Support Center